Login / Signup

Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial.

Ning LiYouzhong ZhangJing WangJian Qing ZhuLi WangXiaohua WuDesheng YaoQiang WuJihong LiuJunying TangRutie YinGe LouRuifang AnGuonan ZhangXiaoping XiaQingshui LiYaping ZhuHong ZhengXinfeng YangYuanjing HuXin ZhangMin HaoYi HuangZhongqiu LinDong WangXiaoqing GuoShuzhong YaoXiaoyun WanHuaijun ZhouLiangqing YaoXielan YangHeng CuiYuanguang MengSongling ZhangJing QuBen ZhangJianjun ZouLing-Ying Wu
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
mutation, and showed a manageable safety profile.
Keyphrases
  • phase iii
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • phase ii study
  • study protocol
  • open label
  • stem cells
  • radiation therapy
  • mesenchymal stem cells
  • smoking cessation
  • replacement therapy